# Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery

> **NCT03660865** · NA · COMPLETED · sponsor: **RxSight, Inc.** · enrollment: 105 (actual)

## Conditions studied

- Aphakia
- Cataract

## Interventions

- **DEVICE:** Light Adjustable lens (LAL) and Light Delivery Device (LDD)
- **DEVICE:** Control IOL

## Key facts

- **NCT ID:** NCT03660865
- **Lead sponsor:** RxSight, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-28
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-04-01
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2021-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03660865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03660865, "Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03660865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*